The participant who triggered a global shutdown of AstraZeneca’s Phase 3 Covid-19 vaccine trials was a woman in the UK who had neurological symptoms consistent with a spinal inflammatory disorder called transverse myelitis, the drug maker’s CEO said.
One investor on the call said Soriot's comments were intended to reassure investors that the company was taking the possible vaccine safety event seriously, and to reverse any damage to the company's stock price. "A vaccine that nobody wants to take is not very useful," said Soriot.
On Wednesday, the company issued a statement, attributed to Soriot, saying AstraZeneca would be guided by a committee of independent experts in determining when to lift the hold on the trial "so that we can continue our work at the earliest opportunity to provide this vaccine broadly, equitably and at no profit during this pandemic."
"To have a clinical hold, as has been placed on AstraZeneca as of yesterday, because of a single serious adverse event is not at all unprecedented," Francis Collins, the director of the National Institutes of Health, told a Senate panel on Wednesday.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
AstraZeneca puts leading COVID-19 vaccine trial on hold over safety concernAstraZeneca Plc on Tuesday said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine because of an unexplained illness in a study participant.
Weiterlesen »
AstraZeneca Pauses COVID-19 Vaccine Trial Due To Volunteer's IllnessNPR's Noel King talks to Paul Offit of the Vaccine Education Center at Children's Hospital of Philadelphia, about the coronavirus vaccine trial developed by AstraZeneca and the University of Oxford.
Weiterlesen »
AstraZeneca Pauses Covid-19 Vaccine Trial After Illness in a U.K. SubjectAstraZeneca said it paused clinical trials of an experimental Covid-19 vaccine after a participant in a U.K. study had an unexplained illness.
Weiterlesen »
AstraZeneca pauses Covid-19 vaccine trial – latest updatesA look at latest developments in global Covid-19 crisis👇: 💉 AstraZeneca suspends vaccine trial after one illness 🇬🇧 UK plans hiring spree to harness big data in virus recovery 🇧🇷 Brazil eyes vaccine rollout in January For more:
Weiterlesen »
AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illnessAstraZeneca Plc said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.
Weiterlesen »
AstraZeneca COVID-19 vaccine tests paused after participant becomes illStudies of AstraZeneca’s COVID-19 vaccine candidate are on hold while the company investigates whether a recipient’s illness is a side effect of the shot.
Weiterlesen »